Product Information
QC MUCUS RELIEF ER 1,200 MG TB is a generic product labeled by Chain Drug Marketing Association, priced at $0.4316 per EA under NDC 83324009614. Its NADAC has been published 97 times since Nov 27, 2024.
FDA first approved this application on May 8, 2020.
Strength
1200 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324009614
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA213420FDA Approved
5/8/2020
On Market Since
8/7/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MUCUS RELIEF ER 1,200 MG TB has been published 97 times since Nov 27, 2024, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4316 per EA |
|---|---|
| All-time high | $0.4764 (Dec 11, 2024) |
| All-time low | $0.4044 (Jan 21, 2026) |
| 52-week high | $0.4613 |
| 52-week low | $0.4044 |
| Median price | $0.4542 |
| Average price | $0.4500 |
| Largest weekly change | +6.3% (Apr 22, 2026) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC MUCUS RELIEF ER 1,200 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RELIEF ER 1,200 MG TB, manufactured by Chain Drug Marketing Association, is $0.4316 per EA (NDC 83324009614), effective Sep 30, 2026.
How has the price of QC MUCUS RELIEF ER 1,200 MG TB changed over time?
Over the history we have for it, the NADAC for QC MUCUS RELIEF ER 1,200 MG TB has declined 9.4%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for QC MUCUS RELIEF ER 1,200 MG TB?
Since Nov 27, 2024, the NADAC for QC MUCUS RELIEF ER 1,200 MG TB has ranged from a low of $0.4044 (Jan 21, 2026) to a high of $0.4764 (Dec 11, 2024), with a median of $0.4542 per EA.
Are there cheaper alternatives to QC MUCUS RELIEF ER 1,200 MG TB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC MUCUS RELIEF ER 1,200 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures QC MUCUS RELIEF ER 1,200 MG TB?
QC MUCUS RELIEF ER 1,200 MG TB (NDC 83324009614) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.